alexa Review of Current Dengue Treatment and Therapeutics in Development | OMICS International
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Review of Current Dengue Treatment and Therapeutics in Development

Fusco DN1* and Chung RT2

1Department of Medicine, Massachusetts General Hospital, Boston, MA 02114

2Director of Hepatology, Gastrointestinal Unit-GI Associates, USA

*Corresponding Author:
Dahlene Fusco, MD, PhD
Department of Medicine
Massachusetts General Hospital
Boston, MA 02114
E-mail: [email protected]

Received Date: May 02, 2014; Accepted Date: May 29, 2014; Published Date: May 31, 2014

Citation: Fusco DN, Chung RT (2014) Review of Current Dengue Treatment and Therapeutics in Development. J Bioanal Biomed S8: 002. doi: 10.4172/1948-593X.S8-002

Copyright: 2014 Fusco DN, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Dengue is an arthropod-borne flavivirus associated with hemorrhagic fever and hemorrhagic shock. Roughly one third of the world population lives at risk of dengue infection, and it is not possible to accurately predict which patients are at risk for severe or fatal infection. Currently, there is no treatment for dengue infection. However, several classes of agents are in under investigation as potential anti-dengue drugs, including direct antivirals, host modula - tors, and RNAi therapeutics. These anti-dengue drugs in development will be reviewed here.

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version